000170525 001__ 170525
000170525 005__ 20240229133716.0
000170525 0247_ $$2doi$$a10.1016/j.radonc.2021.08.016
000170525 0247_ $$2pmid$$apmid:34480959
000170525 0247_ $$2ISSN$$a0167-8140
000170525 0247_ $$2ISSN$$a1879-0887
000170525 0247_ $$2altmetric$$aaltmetric:113618334
000170525 037__ $$aDKFZ-2021-01984
000170525 041__ $$aEnglish
000170525 082__ $$a610
000170525 1001_ $$aSørensen, Brita S$$b0
000170525 245__ $$aDoes the uncertainty in relative biological effectiveness affect patient treatment in proton therapy?
000170525 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2021
000170525 3367_ $$2DRIVER$$aarticle
000170525 3367_ $$2DataCite$$aOutput Types/Journal article
000170525 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1636624298_5417$$xReview Article
000170525 3367_ $$2BibTeX$$aARTICLE
000170525 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000170525 3367_ $$00$$2EndNote$$aJournal Article
000170525 500__ $$a2021 Sep 1;163:177-184
000170525 520__ $$aClinical treatment with protons uses the concept of relative biological effectiveness (RBE) to convert the absorbed dose into an RBE-weighted dose that equals the dose for radiotherapy with photons causing the same biological effect. Currently, in proton therapy a constant RBE of 1.1 is generically used. However, empirical data indicate that the RBE is not constant, but increases at the distal edge of the proton beam. This increase in RBE is of concern, as the clinical impact is still unresolved, and clinical studies demonstrating a clinical effect of an increased RBE are emerging. Within the European Particle Therapy Network (EPTN) work package 6 on radiobiology and RBE, a workshop was held in February 2020 in Manchester with one day of discussion dedicated to the impact of proton RBE in a clinical context. Current data on RBE effects, patient outcome and modelling from experimental as well as clinical studies were presented and discussed. Furthermore, representatives from European clinical proton therapy centres, who were involved in patient treatment, laid out their current clinical practice on how to consider the risk of a variable RBE in their centres. In line with the workshop, this work considers the actual impact of RBE issues on patient care in proton therapy by reviewing preclinical data on the relation between linear energy transfer (LET) and RBE, current clinical data sets on RBE effects in patients, and applied clinical strategies to manage RBE uncertainties. A better understanding of the variability in RBE would allow development of proton treatments which are safer and more effective.
000170525 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000170525 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000170525 7001_ $$aPawelke, Jörg$$b1
000170525 7001_ $$aBauer, Julia$$b2
000170525 7001_ $$aBurnet, Neil G$$b3
000170525 7001_ $$aDasu, Alexandru$$b4
000170525 7001_ $$aHøyer, Morten$$b5
000170525 7001_ $$0P:(DE-He78)b43076fb0a30230e4323887c0c980046$$aKarger, Christian P$$b6$$udkfz
000170525 7001_ $$0P:(DE-He78)4be9ccb23f3e472b97743845cd2b3fe9$$aKrause, Mechthild$$b7$$udkfz
000170525 7001_ $$aSchwarz, Marco$$b8
000170525 7001_ $$aUnderwood, Tracy S A$$b9
000170525 7001_ $$aWagenaar, Dirk$$b10
000170525 7001_ $$aWhitfield, Gillian A$$b11
000170525 7001_ $$aLühr, Armin$$b12
000170525 773__ $$0PERI:(DE-600)1500707-8$$a10.1016/j.radonc.2021.08.016$$gp. S0167814021067104$$p177-184$$tRadiotherapy and oncology$$v163$$x0167-8140$$y2021
000170525 909CO $$ooai:inrepo02.dkfz.de:170525$$pVDB
000170525 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b43076fb0a30230e4323887c0c980046$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000170525 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4be9ccb23f3e472b97743845cd2b3fe9$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000170525 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000170525 9141_ $$y2021
000170525 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2021-01-31$$wger
000170525 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-31
000170525 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-31
000170525 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-31
000170525 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-31
000170525 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-01-31
000170525 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-01-31
000170525 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-31
000170525 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-31
000170525 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-31
000170525 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bRADIOTHER ONCOL : 2019$$d2021-01-31
000170525 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-01-31
000170525 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-01-31
000170525 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2021-01-31
000170525 9201_ $$0I:(DE-He78)E040-20160331$$kE040$$lE040 Med. Physik in der Strahlentherapie$$x0
000170525 9201_ $$0I:(DE-He78)DD01-20160331$$kDD01$$lDKTK DD zentral$$x1
000170525 980__ $$ajournal
000170525 980__ $$aVDB
000170525 980__ $$aI:(DE-He78)E040-20160331
000170525 980__ $$aI:(DE-He78)DD01-20160331
000170525 980__ $$aUNRESTRICTED